1,091
Participants
Start Date
October 31, 2003
Primary Completion Date
January 31, 2008
Study Completion Date
November 30, 2008
Pimecrolimus
Pimecrolimus cream 1 %
Corticosteroid
conventional corticosteroid-based treatment
Dermatology Associates of St. Luke's - Roosevelt, New York
Children's Medical Group, Hopewell Junction
Allegheny General Hospital, Pittsburgh
The Childrens' Hospital of Philadelphia, Philadelphia
Johns Hopkins Hospital, Baltimore
Virginia Clinical Research, Norfolk
Emerald Coast Clinical Research, Pensacola
Dermatology Associates and Research, Coral Gables
Alabama Allergy and Asthma Center, Birmingham
Tennessee Clinical Research Center, Nashville
Dermatology Specialists, Louisville
Central Kentucky Research Associates, Lexington
Indiana University Outpatient Clinical Research, Indianapolis
Dermatology, PLLC, Ann Arbor
Mayo Clinic Rochester, Rochester
Children's Memorial Hospital, Chicago
Central Dermatology, St Louis
Skin Specialists, P.C., Omaha
Rx R & D, Metarie
The Children's Clinic of Jonesboro, Jonesboro
Northwest Arkansas Pediatric Clinic, P.A., Fayetteville
Texas Children's Hospital, BCM, Houston
National Jewish Medical and Research Center, Denver
Alpine Medical Group, LLC, Salt Lake City
Granger Medical Clinic, West Valley City
Children's Hospital San Diego, San Diego
Southern California Research, Mission Viejo
Children's Hospital of Orange County, Orange
Stanford Dermatology Clinic and Clinical Trials Dept, Redwood City
Allergy and Asthma Medical Group of Diablo Valley, Inc./ Clinical Research Division, Walnut Creek
Capital Allergy Respiratory Disease Center, Sacramento
Calcagno Research and Development, Gresham
Oregon Health Science University - Dermatology Dept., Portland
Asthma Inc, Seattle
Children's Hospital - Boston, Boston
Dartmouth-Hitchcock Medical Center/Dermatology Section, Lebanon
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY